CORD presents Rare Disease Drug Strategy Webinars

CORD presents Rare Disease Drug Strategy Webinars

PMPRB: Friend or Foe of Rare Disease Drug Strategy

In February 2019 the federal government committed $1billion over two years starting in 2022 to set up a Canadian Rare Disease Drug Strategy. In August 2019, the government approved regulatory changes to the PMPRB with announced intention to lower drug prices. In theory, are disease drugs would be more accessible. Conversely, pricing could be so severely restricted relative to international norms that many innovative and rare therapies will not be launched in Canada.

On November 6th, Webinar 3 in CORD’s Rare Drug Strategy Consultation, a multi-stakeholder panel will consider the potential impact of the PMPRB revised guidelines on entry and access of rare disease therapies, using “real” case examples. Alternatives will be invited to deliberate on alternatives to the PMPRB guidelines that could better meet the Triple Aim of “timely appropriate patient access”, “optimal, sustainable healthcare expenditure”, and “non-excessive industry compensation that incentivizes launching new therapies and future R&D.”

2020 Consultation Dates
  • Webinar 3: Nov 6 @ 12 pm ET. Addressing individualized needs for rare therapies (Webinar 3 Registration)
  • Webinar 4: Nov 20 @ 12 pm ET. Streamlined rare drug processes across regulatory, HTA, and pricing agencies (Webinar 4 Registration)
  • Webinar 5: Dec 4 @ 12 pm ET. Innovative funding for rare therapies from generic to transformative (Webinar 5 Registration) 


Passed webinar slides can be downloaded here: www.slideshare.net/raredisorders/

Past full webinar are available on CORD's YouTube channel: 

www.youtube.com/user/CORDRareDisorders

 

Back to blog

Leave a public comment:

Please note, comments need to be approved before they are published.

  • The Ustep Walker: A Game-Changer for Atypical Parkinsonism

    The Ustep Walker: A Game-Changer for Atypical P...

      The Ustep walker is a specialized mobility aid designed to support individuals with neurological conditions, including atypical Parkinsonism. Unlike standard walkers, the Ustep is engineered with features that address...

    The Ustep Walker: A Game-Changer for Atypical P...

      The Ustep walker is a specialized mobility aid designed to support individuals with neurological conditions, including atypical Parkinsonism. Unlike standard walkers, the Ustep is engineered with features that address...

  • Understanding Atypical Parkinsonism: A Brain Awareness Week Spotlight

    Understanding Atypical Parkinsonism: A Brain Aw...

    As we celebrate Brain Awareness Week this March 2025, it’s the perfect time to shine a light on the incredible complexity of the human brain—and the challenges it faces when...

    Understanding Atypical Parkinsonism: A Brain Aw...

    As we celebrate Brain Awareness Week this March 2025, it’s the perfect time to shine a light on the incredible complexity of the human brain—and the challenges it faces when...

  • Celebrating Brain Awareness Week 2025 with CCF: Shining a Light on Brain Health

    Celebrating Brain Awareness Week 2025 with CCF:...

    At the Coleen Cunningham Foundation (CCF), we’re excited to join the global community in recognizing Brain Awareness Week, running from March 10-16, 2025. This annual campaign, led by the Dana...

    Celebrating Brain Awareness Week 2025 with CCF:...

    At the Coleen Cunningham Foundation (CCF), we’re excited to join the global community in recognizing Brain Awareness Week, running from March 10-16, 2025. This annual campaign, led by the Dana...

  • Living with Multiple System Atrophy: Tips and Tricks for Navigating Daily Life

    Living with Multiple System Atrophy: Tips and T...

    Multiple System Atrophy (MSA) is a rare and progressive neurodegenerative disorder that affects movement, balance, and the body’s automatic functions—like blood pressure and bladder control. Often mistaken for Parkinson’s disease...

    Living with Multiple System Atrophy: Tips and T...

    Multiple System Atrophy (MSA) is a rare and progressive neurodegenerative disorder that affects movement, balance, and the body’s automatic functions—like blood pressure and bladder control. Often mistaken for Parkinson’s disease...

1 of 4